BDI (Blood Diagnostics, Inc.) Announces Continued Growth Through Q2

BDI, a national leader in the distribution of biopharmaceutical products, announced that sales for the first two quarters of 2008 continued to demonstrate an increase of more than twenty percent (20%) in comparison to same time period in 2007. With a history of strong third and fourth quarter sales, BDI projects that year end revenues, which have grown at an average rate of twenty-three percent (23%) per year from 2004 - 2007, will meet or surpass expectations for the current fiscal year.

"The variables which affect the dynamics of the market sector we serve are unique," said William Shirey, Executive Vice-President of BDI. "Our continued growth accurately illustrates the capabilities of BDI to respond to customer and trade partner demands in a timely and efficient manner providing value unparalleled at the wholesale distributor level."

About BDI

Serving the healthcare community since 1995, Blood Diagnostics, Inc. (BDI), the preeminent national wholesaler of specialty biopharmaceutical products, has built an outstanding reputation as an industry source for products and service. BDI's market focus is evident in its commitment to specialty biotherapeutics, immunologics and hemostatics, including Albumin (Human) USP, intravenous immune globulin (IVIG or IGIV), coagulation factors VIII, IX, and VIIa, as well as hyper-immunes, injectables and physician specialty pharmaceuticals. As a recognized Authorized Distributor of Record for the products it supplies from distribution centers located on both the East and West coast, BDI services the entire country and is fully accredited and insured, fulfilling the licensing requirements in all 50 states.

In an arena where access to pertinent clinical data and updated information on market availability is paramount to patient care, BDI defines its customer-centric approach to serving the nation's healthcare community through innovative inventory management programs, unparalleled customer service, extensive product knowledge, unique promotional services, emergency availability and urgent need delivery. The company serves as a free source for reference material and market data, offering healthcare providers the latest information on products, supply and other industry events. BDI's educational literature and web site -- www.ivig.com -- serve as open-access resources, contributing to the promotion of the biopharmaceutical industry and the education of both the healthcare community and general populace.